Looking forward to hearing what this panel, including @ESchattner, has to say about “drawing the line on buying time: how much is too much?” #schd19

If biosimilars are supposed to lead to decreased drug costs, why is the filgrastim biosimilar (Zarxio) more expensive than the original (neupogen)? #schd19

.@gary_lyman talking about biosimilar at #schd19. Biosimilar are expected to decrease drug costs. The first biosimilar for Trastuzumab was approved 12/2017 but it not yet available to patients. Sigh 😔

So much this slide, in terms of “why did I get cancer?”
To me, this is also a slide that can be adapted to “why am I #NotDeadYet but many of my metastatic friends are? Genotype + environment + treatment + sheer dumb luck. #schd19

Like those of us with metastatic cancers living longer, those living with AIDS are having to deal with accelerated aging due to treatment , plus they’re developing non-AIDS related cancers a but are less likely to be offered treatment #schd19

Learning about the successes in treatment of HIV/AIDs with renowned expert Dr David Aboulafia - and the challenges as people become complacent about safer sex practices. #schd19

The US spends 3 times more on health care administration than it does on cancer care. This is sickening #SCHD19

Get ready for a lively debate on single payer vs multi-payer health care. Follow along on the @btfoundation twitter feed #schd19

.@binayshah: we cannot take baby steps when it comes to changing the way health care is delivered in the US. #schd19

This 👇🏻 We MUST ensure that every human in this planet has access to health care. #schd19

Dr Ben Anderson makes an important point: in terms of influencing policy, advocates are way more important than doctors or health care systems because we advocates are the voters #schd19

How can we gather and use real world data? One way is through @ASCO’s CancerLinQ, it’s not easy & it’s not cheap, but it’s necessary #schd19

.@ASCO to address rural cancer care disparities @CliffordHudis #schd19

.@CliffordHudis discussing success - and failures - in addressing cancer care disparities in the US. While racial and gender disparities are overall improving, the gap between urban and rural areas worsen. #schd19

Self collection is preferred even here in the US #schd19

Dr Winn. Even here in the US, where cervical cancer deaths are rare (2.7/100000), in a predominantly Puerto Rican neighborhood in Chicago, the death rate is double that. The problem isn’t lack of tech or treatment, the problem is getting tech and treatment to everyone. #schd19

#schd19 Dr. Robert Winn speaking about disparities - and how supposed color and gender blind computers and AI may perpetuate disparities.

Fellow #metastaticBC patient,
singer, and general woman extraordinaire @cierrasisters introducing the first speakers #schd19